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Background: Data on influenza in the healthcare setting are often based on retrospective investigations of
outbreaks and a few studies described influenza during several consecutive seasons.
The aim of the present work is to report data on influenza like illness (ILI) and influenza from 5-year prospective
surveillance in a short-stay geriatrics unit.
Findings: A short stay geriatrics unit underwent 5 years of ILI surveillance from November 2004 to March 2009,
with the aim of describing ILI in a non-outbreak context. The study was proposed to patients who presented ILI,
defined as fever >37.8°C or cough or sore throat. Among 1,353 admitted patients, 115 presented an ILI, and 34 had
hospital-acquired ILI (HA-ILI). Influenza was confirmed in 23 patients, 13 of whom had been vaccinated. Overall
attack rates were 2.78% and 0.02% for HA-ILI and HA-confirmed influenza respectively, during the 5 seasons.
Conclusions: This 5-year surveillance study supports the notion that influenza infections are common in hospitals,
mostly impacting the elderly hospitalized in short-stay units. It highlights the need for appropriate control measures
to prevent HA-ILI in geriatric units and protect elderly patients.
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Background
In healthcare settings, as in the community, influenza
can cause severe illness or death in people at high risk,
especially the elderly, since most mortality attributable
to influenza occurs among people aged 65 years or
older [1-5].
Most estimates of hospital-acquired influenza frequency
are based on reports of outbreaks that occurred in long-
term care units or nursing homes, where attack rate varied
between 28% and 48% in 60 years-old persons [6]. On the
one hand, these figures could have been overestimated
because outbreaks with a large number of cases tend to* Correspondence: philippe.vanhems@chu-lyon.fr
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reproduction in any medium, provided the orbe reported more often in the literature. On the other
hand, influenza in elderly patients may be underestimated
because clinical presentation can be altered by symptoms
and treatments of pre-existing diseases [7,8]. A previous
study explored the predictive values of influenza symp-
toms among hospitalized patients [9]. Despite a different
study design and objective, it illustrated the need for
additional data on influenza in the hospital context.
Data from long-term prospective investigations of in-
fluenza, especially hospital-acquired influenza, are lack-
ing. The aim of the present study is to report data on
influenza like illness (ILI) and influenza after 5-years
prospective surveillance in a short-stay geriatric unit of a
French university hospital.Methods
Prospective ILI surveillance was implemented between
November and March from 2004 to 2007 in 32 wards of
Edouard Herriot University Hospital in Lyon, Francetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Characteristics of patients with influenza like





n = 81 n = 34
Gender: men/women 23/58 9/25
Median age (range, years) 88 (69–103) 88 (77–99)
Vaccination against influenza
During the ILI season 45 (55.6%) 22 (64.7%)
Every season 42 (51.9%) 19 (55.9%)
Symptoms
Fever > 37.8°C 47 (73.7%)* 23 (67.6%)
Cough 69 (85.2%) 30 (88.2%)
Sore throat 10 (12.3%) 5 (14.7%)




39 (48.2%) 18 (52.9%)
Infectious disease with fever 34 (42.0%) 2 (5.9%)
Fall or confusion 16 (19.8%) 9 (26.5%)
Other 14 (17.3%) 10 (29.4%)
Treatment against ILI
Antipyretics 49 (60.5%) 21 (61.8%)
Antibiotics 75 (92.6%) 23 (67.6%)
Antiviral treament 0 (0%) 0 (0%)
Lab results
Influenza 17 (21.0%) 6 (17.6%)
Respiratory Syntytial Virus
(RVS)
5 (6.2%) 0 (0%)
Influenza and RVS coinfection 1 (1.2%) 0 (0%)
Rhinovirus 3 (3.7%) 1 (2.9%)
Herpes Simplex Virus (HSV) 1 (1.2%) 0 (0%)
Parainfluenzae 1(1.2%) 0 (0%)
No detected virus 53 (65.4%) 27 (79.4%)
Complications
Cardiac 3 (3.7%) 0 (0%)
Respiratory 6 (7.4%) 1 (2.9%)
Death 5 (6.2%) 4 (4.8%)
*ILI Percentages calculated for patients, n = 61; Data unknown for the
other individuals.
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2008–2009. The geriatric unit, which is an 18-beds post-
emergency hospitalization unit, participated continuously
from 2004 to 2009, providing a unique opportunity to
describe influenza and ILI during 5 consecutive years of
geriatrics patient surveillance.
Study participation was proposed to each patient who
presented ILI at admission or during hospitalization. ILI
was defined as fever >37.8°C or cough or sore throat.
Our definition converged towards that of the World
Health Organization (fever >37.8°C with cough or sore
throat), which was sensitive (98.4-100%) but not specific
(12.9-21.5%) [11].
The following information was collected by oral inter-
view and via medical charts: gender (male, female), age
at admission, reason of admission (cardio respiratory
disease without fever, infectious disease with fever, fall/
confusion or other), vaccination against influenza during
the ILI season (yes, no) and every season (yes, no),
symptoms (fever > 37.8°C, cough and sore throat), com-
plications (cardiac, respiratory) and death.
After the interview, a nasal swab was performed by a
research assistant and influenza virus infection was con-
firmed by enzyme-linked immunosorbent assay and re-
verse transcription-polymerase chain reaction on viral
cultures. Nasal swab samples were analyzed by the
“Centre National de Référence de la grippe”. Respiratory
syncytial virus (RSV), rhinovirus, parainfluenza virus and
herpes simplex virus (HSV) were other viruses detected.
ILI was classified in 2 categories: community-associated
ILI (CA-ILI), defined as patients who acquired ILI in the
community or prior to hospitalization, and hospital-
acquired ILI (HA-ILI), defined as patients with ILI ac-
quired after admission. We considered ILI with onset
occurring on the day of admission as CA-ILI but the time
between admission and ILI onset was investigated.
To calculate attack rates, the number of monthly ad-
missions to the unit was obtained from the hospital in-
formation system for the study period. Attack rates were
calculated as the number of ILI or confirmed influenza
among patients divided by the number of admissions at
risk during the study period. In this calculation, we
excluded, from the denominator, admissions for which
patients presented with ILI or influenza (i.e. CA-ILI or
CA-confirmed influenza) since we considered these pa-
tients to be no more at risk of influenza infection.
The data were analyzed by SPSS Statistics 17.0 (SPSS,
Inc., Chicago, IL).
Informed consent was obtained from all patients. The
study was approved by the French national bodies respon-
sible for ethics and privacy, the “Commission Nationale de
l’Informatique et des Libertés” (CNIL, http://www.cnil.fr/)
and the “Comité de Protection des personnes” (http://
www.cppsudest2.com/) of the hospital.Results
During the 5-year surveillance period, 1,353 patients
were admitted in the unit and 115 patients presented ILI
either at admission or during hospitalization (overall ILI
burden of 8.5%). Table 1 reports on these 115 patients.
No obvious difference was observed between CA-ILI
and HA-ILI, except for a higher antibiotic use in CA-ILI.
Among these 115 patients, 81 (70.4%) were CA-ILI and
34 (29.6%) were HA-ILI.
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80 patients (69.6%) and at least one virus was detected
in 35 patients (30.4%). Among these 35 patients, 23
(68.6%) presented a confirmed influenza and 11 (21.4%)
had another respiratory virus: 5 had a respiratory syncytial
virus (RSV), 4 had a rhinovirus, 1 has a herpes simplex
virus (HSV) and 1 has a parainfluenza virus.
Among the 81 CA-ILI, 17 (22.2%) had confirmed
influenza, 10 (12.3%) were infected with another virus
(5 patients with a RSV, 3 with a rhinovirus, 1 with a
HSV and 1 with a parainfluenza virus), 1 patient was
coinfected with influenza and RSV, and no virus was
identified in 53 (65.4%).
Among the 34 HA-ILI, influenza was confirmed in 6
(17.6%) patients and no virus was identified in 27
(79.4%). One patient was infected with rhinovirus.
Figure 1 reports the distribution of patients according
to the duration between ILI onset and admission. Among
the 34 HA-ILI, 12 (35.3%), 6 (17.6%), 3 (8.8%) and 13
(38.3%) presented ILI 24 hours, 48 hours, 72 hours
and >72 hours after admission respectively. Among
the 6 patients who acquired confirmed influenza in
hospital, 3 were infected 24 hours after admission and
the others 3, 9 and 27 days after admission.
Sixty-seven (58.3%) patients had been vaccinated against
influenza (45 CA-ILI and 22 HA-ILI). Among these vacci-
nated patients, 13 (19.4%) declared confirmed influenza
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Figure 1 Distribution of patients according to the duration between
according to the delay between onset of symptoms and admission (days)
hospital, Lyon (France).strain different from the vaccine strain (due to a mismatch
in 2005). Among the 6 hospital-acquired influenza cases,
5 women had been vaccinated against influenza, 3 of them
had an isolated strain different from the vaccine strain.
During ILI, 4 (3.5%) patients had cardiac complica-
tions and 6 (5.2%) had respiratory complications. Nine
patients (7.8%) died from causes not directly attributable
to ILI but 4 of them had HA-ILI.
Attack rates for HA-ILI regardless of viral identification
were 3.7, 5.5, 1.8, 0.4 and 2.5 per 100 admissions from
2004–2005 to 2008–2009 respectively. Corresponding
attack rates for HA-confirmed influenza were 1.4, 0.4,
0.3, 0 and 0 per 100 admissions.
Discussion
Our findings indicate that HA-ILI occurred regularly
and that influenza viruses are involved irregularly
[5,6,12]. Our results revealed a number of infections by
influenza viruses weaker than in outbreaks reports and
that other viruses circulated in the hospitals, something
that is rarely reported. The overall ILI attack rate in our
geriatrics unit was 2.7%, highly comparable to the attack
rate recorded by the “Groupes Régionaux d’Observation
de la Grippe” (France), with an estimate of 2.64% for
people aged ≥ 65 years during the same period [13]. For
comparison, community epidemic curves for influenza
from the “Groupes Régionaux d’Observation de la Grippe”
are provided in Additional file 1.4 5 6 7 8 9 10 >10
Confirmed influenza A or B cases
ILI cases without viral identification
Delay (days)
Hospital-Acquired cases 
ILI onset and admission. Distribution of number of patients with ILI
in geriatric unit during 5 years of surveillance at E. Herriot University
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5-year prospective study also gives an opportunity to dis-
cuss ILI and HA-ILI definitions and influenza vaccination.
The choice of ILI definition with broad criteria can be
seen as not being adapted in our study but, with a more
specific definition (e.g., fever >39°C with myalgia and
a respiratory symptom), 23 (95.8%) patients with con-
firmed influenza would not have been included. This
suggests that ILI definition is a key component of in-
fluenza surveillance in hospitals, especially since the
elderly do not manifest influenza symptoms commonly
found in the general population and co-morbidities alter
influenza infection [7].
Our definition of HA-ILI can be also seen as not being
adapted. We defined HA-ILI as ILI after admission but
various definitions exist concerning nosocomial influ-
enza. In our study 50% of hospital-acquired confirmed
influenza declared their symptoms 24 hours after admis-
sion. For influenza, it has been suggested that 30% of
infected persons may develop symptoms within one day,
and 80% within two days, after infection, with an average
incubation period of 1.9 days [14,15]. We, therefore,
consider that HA-ILI may be the result of infection by
the virus in hospital within the first day but also within
the second day of admission. Altogether, the definition
of nosocomial ILI or nosocomial influenza remains an
open issue.
Several studies have demonstrated the effectiveness of
influenza vaccination in seniors [16], although potential
biases could represent certain limitation [17,18] and age-
related immunodeficiency could impair vaccine efficacy
[19]. In our investigation, more than 50% of individuals
with confirmed influenza had been vaccinated. This high
rate of vaccine failure could be related to low efficacy of
influenza vaccination in the elderly, as reported previ-
ously [20]. However, we noticed that 6 individuals had
been infected with a strain different from the vaccine
strain, and that 68% of ILI occurred in February or
March, more than 3 months after the influenza vaccin-
ation campaign. In France, influenza vaccination is rec-
ommended for people aged 65 years or older but is not
mandatory. We suppose it may explain the low influenza
vaccine coverage in this population.
The strength of our study is its prospective design and
5-year duration of surveillance. However, selection bias
towards more severe cases could have been a limitation
since hospitalized patients in a university centre could
be more affected by underlying diseases than in other
geriatric institutions, such as long-term care facilities.
Influenza is difficult to detect in hospital as its diagno-
sis is based on nonspecific symptoms. Treatment may
mask the symptoms and the diagnosis of suspected
nosocomial pulmonary infection is mainly attributed to
bacterial rather than viral identification, as may beattested by the frequent use of antibiotherapy in our
study. Although viruses are supposed to be a major
cause of nosocomial infection [21,22], a lack of data pre-
vents us from estimating the proportions of viral infec-
tions among nosocomial infections. A proportion of 5%
has been suggested, but this value is probably underesti-
mated. The low frequency of viral nosocomial infections
compared to bacterial infections may be explained by
more difficult detection due to longer and varying incu-
bation times, a significant proportion of asymptomatic
infections, or a low rate of antiviral resistance. Not sur-
prisingly, our study reported low attack rates and, fur-
thermore, a few other respiratory viruses were detected.
Conclusion
Although hospital-acquired influenza detection and esti-
mates are imprecise, nosocomial influenza is a reality with
a potentially significant impact in the elderly hospitalized
in short-stay units. While the beneficial effects of vaccinat-
ing the elderly are being debated, it appears important to
protect this vulnerable population by decreasing its expos-
ure to the virus, by vaccinating healthcare workers and by
applying infection control measures including hand wash-
ing, disinfection and use of masks [23].
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